指南与共识泌尿生殖腹部CTMRPET

美国放射学会适宜性标准®前列腺癌治疗后随访:2022年更新

ACR Appropriateness Criteria® Post-Treatment Follow-up of Prostate Cancer: 2022 Update.
指南 / 共识 · J Am Coll Radiol · 2023-01-01

该指南将复发和转移性前列腺癌分为根治性前列腺切除术后、非手术局部及盆腔治疗后临床怀疑残留或复发、以及系统治疗(雄激素剥夺治疗、化疗、免疫治疗)的转移性前列腺癌三类,基于文献综述和多学科专家小组采用RAND/UCLA适宜性方法和GRADE对影像检查适宜性进行评级并给出推荐。

要点

  • 指南按三大临床场景组织影像推荐:根治性前列腺切除术后、非手术局部/盆腔治疗后、系统治疗的转移性前列腺癌。
  • 指南制定采用RAND/UCLA适宜性方法与GRADE对影像和治疗的适宜性进行评级。
  • 证据不足或模棱两可时,可由专家意见补充现有证据来推荐影像或治疗。

核心结论

  • 该文件综述了上述三类临床场景中影像检查的当前文献并给出相应影像推荐。

研究设计与样本

  • 美国放射学会适宜性标准为针对特定临床情况的循证指南,由多学科专家小组每年审查。
  • 指南制定与修订包括对同行评审期刊当前医学文献的广泛分析,并应用RAND/UCLA适宜性方法和GRADE对影像及治疗程序的适宜性进行评级。
  • 证据缺乏或模棱两可时,专家意见可补充现有证据以推荐影像或治疗。

诊断标准与关键数值

  • 复发和转移性前列腺癌分为三类:根治性前列腺切除术后临床怀疑残留或复发、非手术局部及盆腔治疗后临床怀疑残留或复发、系统治疗(雄激素剥夺治疗、化疗、免疫治疗)的转移性前列腺癌。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 证据缺乏或模棱两可时,专家意见可补充现有证据以推荐影像或治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Prostate cancer has a wide spectrum ranging between low-grade localized disease and castrate-resistant metastatic disease. Although whole gland and systematic therapies result in cure in the majority of patients, recurrent and metastatic prostate cancer can still occur. Imaging approaches including anatomic, functional, and molecular modalities are continuously expanding. Currently, recurrent and metastatic prostate cancer is grouped in three major categories: 1) Clinical concern for residual or recurrent disease after radical prostatectomy, 2) Clinical concern for residual or recurrent disease after nonsurgical local and pelvic treatments, and 3) Metastatic prostate cancer treated by systemic therapy (androgen deprivation therapy, chemotherapy, immunotherapy). This document is a review of the current literature regarding imaging in these settings and the resulting recommendations for imaging. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment.

来源:J Am Coll Radiol,查看原文。版权归原作者所有。

引用

  1. Turkbey B, Oto A, Allen BC, et al. ACR Appropriateness Criteria® Post-Treatment Follow-up of Prostate Cancer: 2022 Update. J Am Coll Radiol. 2023. PMID: 37236741. doi:10.1016/j.jacr.2023.02.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。